150
Participants
Start Date
November 1, 2022
Primary Completion Date
November 11, 2024
Study Completion Date
November 11, 2024
APHD-012
Distal jejunal-release dextrose beads (Aphaia technology, AT)
APHD-012P
Distal jejunal-release placebo beads
Universitätsklinikum Ruppin-Brandenburg, Neuruppin
Universitätsklinikum Schleswig-Holstein, Lübeck
"LTD Israeli-Georgian Medical Research Clinic Healthycore", Tbilisi
"LTD Acad. G. Chapidze Emergency Cardiology Center", Tbilisi
"LTD Diacor", Tbilisi
"LTD National Institute of Endocrinology", Tbilisi
"LTD Tbilisi Heart Center", Tbilisi
GCM Medilcal Group, San Juan
FDI Clinical Research, San Juan
Lead Sponsor
Aphaia Pharma US LLC
INDUSTRY